Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement
• Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Harrison, R. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Umfang: |
5 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes - Gibson, Diane M. ELSEVIER, 2017, an international journal : official publication of the Society of Gynecologic Oncologists [u.a.], Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:163 ; year:2021 ; number:3 ; pages:448-452 ; extent:5 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ygyno.2021.10.008 |
|---|
| Katalog-ID: |
ELV055952976 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV055952976 | ||
| 003 | DE-627 | ||
| 005 | 20230624224704.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220105s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ygyno.2021.10.008 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica |
| 035 | |a (DE-627)ELV055952976 | ||
| 035 | |a (ELSEVIER)S0090-8258(21)01452-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.11 |2 bkl | ||
| 100 | 1 | |a Harrison, R. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement |
| 264 | 1 | |c 2021 | |
| 300 | |a 5 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. | ||
| 700 | 1 | |a Zighelboim, I. |4 oth | |
| 700 | 1 | |a Cloven, N.G. |4 oth | |
| 700 | 1 | |a Marcus, J.Z. |4 oth | |
| 700 | 1 | |a Coleman, R.L. |4 oth | |
| 700 | 1 | |a Karam, A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Gibson, Diane M. ELSEVIER |t Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |d 2017 |d an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] |g Orlando, Fla |w (DE-627)ELV000708127 |
| 773 | 1 | 8 | |g volume:163 |g year:2021 |g number:3 |g pages:448-452 |g extent:5 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ygyno.2021.10.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.11 |j Präventivmedizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 163 |j 2021 |e 3 |h 448-452 |g 5 | ||
| author_variant |
r h rh |
|---|---|
| matchkey_str |
harrisonrzighelboimiclovenngmarcusjzcole:2021----:eodrctrdcieugrfreurnoainacrngci |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.11 |
| publishDate |
2021 |
| allfields |
10.1016/j.ygyno.2021.10.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica (DE-627)ELV055952976 (ELSEVIER)S0090-8258(21)01452-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.11 bkl Harrison, R. verfasserin aut Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement 2021 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. Zighelboim, I. oth Cloven, N.G. oth Marcus, J.Z. oth Coleman, R.L. oth Karam, A. oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:163 year:2021 number:3 pages:448-452 extent:5 https://doi.org/10.1016/j.ygyno.2021.10.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 163 2021 3 448-452 5 |
| spelling |
10.1016/j.ygyno.2021.10.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica (DE-627)ELV055952976 (ELSEVIER)S0090-8258(21)01452-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.11 bkl Harrison, R. verfasserin aut Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement 2021 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. Zighelboim, I. oth Cloven, N.G. oth Marcus, J.Z. oth Coleman, R.L. oth Karam, A. oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:163 year:2021 number:3 pages:448-452 extent:5 https://doi.org/10.1016/j.ygyno.2021.10.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 163 2021 3 448-452 5 |
| allfields_unstemmed |
10.1016/j.ygyno.2021.10.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica (DE-627)ELV055952976 (ELSEVIER)S0090-8258(21)01452-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.11 bkl Harrison, R. verfasserin aut Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement 2021 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. Zighelboim, I. oth Cloven, N.G. oth Marcus, J.Z. oth Coleman, R.L. oth Karam, A. oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:163 year:2021 number:3 pages:448-452 extent:5 https://doi.org/10.1016/j.ygyno.2021.10.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 163 2021 3 448-452 5 |
| allfieldsGer |
10.1016/j.ygyno.2021.10.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica (DE-627)ELV055952976 (ELSEVIER)S0090-8258(21)01452-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.11 bkl Harrison, R. verfasserin aut Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement 2021 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. Zighelboim, I. oth Cloven, N.G. oth Marcus, J.Z. oth Coleman, R.L. oth Karam, A. oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:163 year:2021 number:3 pages:448-452 extent:5 https://doi.org/10.1016/j.ygyno.2021.10.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 163 2021 3 448-452 5 |
| allfieldsSound |
10.1016/j.ygyno.2021.10.008 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica (DE-627)ELV055952976 (ELSEVIER)S0090-8258(21)01452-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.11 bkl Harrison, R. verfasserin aut Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement 2021 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. Zighelboim, I. oth Cloven, N.G. oth Marcus, J.Z. oth Coleman, R.L. oth Karam, A. oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:163 year:2021 number:3 pages:448-452 extent:5 https://doi.org/10.1016/j.ygyno.2021.10.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 163 2021 3 448-452 5 |
| language |
English |
| source |
Enthalten in Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes Orlando, Fla volume:163 year:2021 number:3 pages:448-452 extent:5 |
| sourceStr |
Enthalten in Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes Orlando, Fla volume:163 year:2021 number:3 pages:448-452 extent:5 |
| format_phy_str_mv |
Article |
| bklname |
Präventivmedizin |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| authorswithroles_txt_mv |
Harrison, R. @@aut@@ Zighelboim, I. @@oth@@ Cloven, N.G. @@oth@@ Marcus, J.Z. @@oth@@ Coleman, R.L. @@oth@@ Karam, A. @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000708127 |
| dewey-sort |
3610 |
| id |
ELV055952976 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055952976</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624224704.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ygyno.2021.10.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055952976</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0090-8258(21)01452-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Harrison, R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zighelboim, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cloven, N.G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marcus, J.Z.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coleman, R.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karam, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Gibson, Diane M. ELSEVIER</subfield><subfield code="t">Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes</subfield><subfield code="d">2017</subfield><subfield code="d">an international journal : official publication of the Society of Gynecologic Oncologists [u.a.]</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000708127</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:163</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:448-452</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ygyno.2021.10.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.11</subfield><subfield code="j">Präventivmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">163</subfield><subfield code="j">2021</subfield><subfield code="e">3</subfield><subfield code="h">448-452</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| author |
Harrison, R. |
| spellingShingle |
Harrison, R. ddc 610 bkl 44.11 Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement |
| authorStr |
Harrison, R. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000708127 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.11 bkl Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement |
| topic |
ddc 610 bkl 44.11 |
| topic_unstemmed |
ddc 610 bkl 44.11 |
| topic_browse |
ddc 610 bkl 44.11 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
i z iz n c nc j m jm r c rc a k ak |
| hierarchy_parent_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| hierarchy_parent_id |
ELV000708127 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000708127 |
| title |
Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement |
| ctrlnum |
(DE-627)ELV055952976 (ELSEVIER)S0090-8258(21)01452-9 |
| title_full |
Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement |
| author_sort |
Harrison, R. |
| journal |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| journalStr |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
448 |
| author_browse |
Harrison, R. |
| container_volume |
163 |
| physical |
5 |
| class |
610 VZ 44.11 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Harrison, R. |
| doi_str_mv |
10.1016/j.ygyno.2021.10.008 |
| dewey-full |
610 |
| title_sort |
secondary cytoreductive surgery for recurrent ovarian cancer: an sgo clinical practice statement |
| title_auth |
Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement |
| abstract |
• Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. |
| abstractGer |
• Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. |
| abstract_unstemmed |
• Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
3 |
| title_short |
Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement |
| url |
https://doi.org/10.1016/j.ygyno.2021.10.008 |
| remote_bool |
true |
| author2 |
Zighelboim, I. Cloven, N.G. Marcus, J.Z. Coleman, R.L. Karam, A. |
| author2Str |
Zighelboim, I. Cloven, N.G. Marcus, J.Z. Coleman, R.L. Karam, A. |
| ppnlink |
ELV000708127 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.ygyno.2021.10.008 |
| up_date |
2024-07-06T19:00:00.717Z |
| _version_ |
1803857324375277568 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV055952976</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624224704.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ygyno.2021.10.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001673.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV055952976</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0090-8258(21)01452-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Harrison, R.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Available prospective evidence is mixed for whether SCR improves overall survival. • Reviewing similarities & differences of clinical trials is key to applying findings to practice. • GOG-0213, DESKTOP III, and SOC-1 enrolled highly selected cohorts of patients. • Patient selection is critical when considering SCR as part of treatment for recurrent disease. • The goal of SCR should be complete resection of all visible disease.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zighelboim, I.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cloven, N.G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marcus, J.Z.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Coleman, R.L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karam, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Gibson, Diane M. ELSEVIER</subfield><subfield code="t">Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes</subfield><subfield code="d">2017</subfield><subfield code="d">an international journal : official publication of the Society of Gynecologic Oncologists [u.a.]</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000708127</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:163</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:448-452</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ygyno.2021.10.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.11</subfield><subfield code="j">Präventivmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">163</subfield><subfield code="j">2021</subfield><subfield code="e">3</subfield><subfield code="h">448-452</subfield><subfield code="g">5</subfield></datafield></record></collection>
|
| score |
7.3987617 |